SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-23-091525
Filing Date
2023-08-14
Accepted
2023-08-14 17:19:48
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 tm2323492-1_s3.htm S-3 221821
2 EXHIBIT 5.1 tm2323492d2_ex5-1.htm EX-5.1 10237
3 EXHIBIT 23.1 tm2323492d2_ex23-1.htm EX-23.1 1843
4 EX-FILING FEES tm2323492d2_ex-filingfees.htm EX-FILING FEES 13653
5 GRAPHIC tm2323492d2_ex5-1img001.jpg GRAPHIC 3063
6 GRAPHIC lg_outlooktherapeutics-4c.jpg GRAPHIC 50660
  Complete submission text file 0001104659-23-091525.txt   322974
Mailing Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830
Business Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830 6096193990
Outlook Therapeutics, Inc. (Filer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: S-3 | Act: 33 | File No.: 333-273979 | Film No.: 231172070
SIC: 2836 Biological Products, (No Diagnostic Substances)